Nanjing Well Pharmaceutical Co Ltd (603351) - Total Liabilities

Latest as of September 2025: CN¥819.31 Million CNY ≈ $119.89 Million USD

Based on the latest financial reports, Nanjing Well Pharmaceutical Co Ltd (603351) has total liabilities worth CN¥819.31 Million CNY (≈ $119.89 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Nanjing Well Pharmaceutical Co Ltd - Total Liabilities Trend (2014–2024)

This chart illustrates how Nanjing Well Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 603351 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Nanjing Well Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Nanjing Well Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Icon Offshore Bhd KLSE:5255	Malaysia	RM525.08 Million
Jiangsu Huifeng Agrochemical Co Ltd SHE:002496	China	CN¥987.73 Million
Summit Hotel Properties Inc NYSE:INN	USA	$1.55 Billion
Jilin University Zhengyuan Info Tech SHE:003029	China	CN¥589.71 Million
Guangzhou Boji Medical and Biotechnological Co Ltd SHE:300404	China	CN¥569.21 Million
Songz Automobile Air Conditioning Co Ltd SHE:002454	China	CN¥3.64 Billion
Shenzhen Longli Technology Co Ltd Class A SHE:300752	China	CN¥1.02 Billion
Ginkgo Bioworks Holdings NYSE:DNA	USA	$589.92 Million

Liability Composition Analysis (2014–2024)

This chart breaks down Nanjing Well Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Nanjing Well Pharmaceutical Co Ltd stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.29	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.47	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.32	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Nanjing Well Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Nanjing Well Pharmaceutical Co Ltd (2014–2024)

The table below shows the annual total liabilities of Nanjing Well Pharmaceutical Co Ltd from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥672.72 Million ≈ $98.44 Million	-1.97%
2023-12-31	CN¥686.22 Million ≈ $100.42 Million	+4.65%
2022-12-31	CN¥655.76 Million ≈ $95.96 Million	+43.80%
2021-12-31	CN¥456.01 Million ≈ $66.73 Million	+35.41%
2020-12-31	CN¥336.75 Million ≈ $49.28 Million	+55.15%
2019-12-31	CN¥217.06 Million ≈ $31.76 Million	+12.12%
2018-12-31	CN¥193.59 Million ≈ $28.33 Million	+0.45%
2017-12-31	CN¥192.73 Million ≈ $28.20 Million	+23.35%
2016-12-31	CN¥156.25 Million ≈ $22.86 Million	-19.05%
2015-12-31	CN¥193.01 Million ≈ $28.24 Million	+7.86%
2014-12-31	CN¥178.94 Million ≈ $26.19 Million	--

About Nanjing Well Pharmaceutical Co Ltd

SHG:603351 China Drug Manufacturers - Specialty & Generic

Market Cap

$489.53 Million

CN¥3.35 Billion CNY

Market Cap Rank

#12492 Global

#3682 in China

Share Price

CN¥24.70

Change (1 day)

+1.02%

52-Week Range

CN¥23.50 - CN¥32.52

All Time High

CN¥40.56